Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.
about
Formation of soluble amyloid oligomers and amyloid fibrils by the multifunctional protein vitronectinThe coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathwayAutoproteolytic fragments are intermediates in the oligomerization/aggregation of the Parkinson's disease protein alpha-synuclein as revealed by ion mobility mass spectrometryStructures of rat and human islet amyloid polypeptide IAPP(1-19) in micelles by NMR spectroscopyMembrane curvature induction and tubulation are common features of synucleins and apolipoproteins.Fenton chemistry and oxidative stress mediate the toxicity of the beta-amyloid peptide in a Drosophila model of Alzheimer's diseaseCytoplasmic penetration and persistent infection of mammalian cells by polyglutamine aggregatesProtein folding: then and nowMolecular origin of polyglutamine aggregation in neurodegenerative diseases.The Rationale for Insulin Therapy in Alzheimer's DiseaseCommon mechanisms involved in Alzheimer's disease and type 2 diabetes: a key role of chronic bacterial infection and inflammationInsights into Mechanisms of Chronic NeurodegenerationMolecular Structure, Membrane Interactions, and Toxicity of the Islet Amyloid Polypeptide in Type 2 Diabetes MellitusTargeting heat shock proteins to modulate α-synuclein toxicityThe Effects of Lipid Membranes, Crowding and Osmolytes on the Aggregation, and Fibrillation Propensity of Human IAPPDisrupting self-assembly and toxicity of amyloidogenic protein oligomers by "molecular tweezers" - from the test tube to animal modelsTangles, Toxicity, and Tau Secretion in AD - New Approaches to a Vexing ProblemA window into the heterogeneity of human cerebrospinal fluid Aβ peptidesOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesMembrane Permeabilization by Oligomeric α-Synuclein: In Search of the MechanismSeeking a mechanism for the toxicity of oligomeric α-synucleinAntidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophyProtein misfolding and aggregation in Alzheimer's disease and type 2 diabetes mellitusExploring new biological functions of amyloids: bacteria cell agglutination mediated by host protein aggregationBisphenol A accelerates toxic amyloid formation of human islet amyloid polypeptide: a possible link between bisphenol A exposure and type 2 diabetesMethylated BSA mimics amyloid-related proteins and triggers inflammationNanoscale Synaptic Membrane Mimetic Allows Unbiased High Throughput Screen That Targets Binding Sites for Alzheimer's-Associated Aβ Oligomers.Aβ42 assembles into specific β-barrel pore-forming oligomers in membrane-mimicking environments.Aqueous, Unfolded OmpA Forms Amyloid-Like Fibrils upon Self-Association.The stability of cylindrin β-barrel amyloid oligomer models-a molecular dynamics study.Amyloid Beta annular protofibrils in cell processes and synapses accumulate with aging and Alzheimer-associated genetic modificationAnnular protofibrils are a structurally and functionally distinct type of amyloid oligomer.Biophysics of α-synuclein membrane interactions.Implications of protein structure instability: from physiological to pathological secondary structure.Membrane interactions of a self-assembling model peptide that mimics the self-association, structure and toxicity of Abeta(1-40).Two disaccharides and trimethylamine N-oxide affect Abeta aggregation differently, but all attenuate oligomer-induced membrane permeability.Structural differences between Abeta(1-40) intermediate oligomers and fibrils elucidated by proteolytic fragmentation and hydrogen/deuterium exchange.Simultaneous monitoring of peptide aggregate distributions, structure, and kinetics using amide hydrogen exchange: application to Abeta(1-40) fibrillogenesisExploring the mechanism of beta-amyloid toxicity attenuation by multivalent sialic acid polymers through the use of mathematical models.Cytoplasmic prion protein induces forebrain neurotoxicity
P2860
Q21202837-7B398E51-08E6-45A3-A7F4-DC82560F04A9Q24294387-DF4294CF-C3B9-40E2-B61C-28C490CDAE3DQ24632795-933920B2-C685-40A1-8EAA-70261D57A7D5Q24633016-1B1FAF63-62E5-44AD-A820-4CBA142EB2E3Q24633488-9999921D-571A-45B3-9E3F-9F47170917E4Q24656549-BA68421A-3F59-4C31-8928-96CEEA164AE8Q24657543-F2F6BB72-FF4D-4500-8E98-746EDB6138CFQ24671711-830E8626-9163-486D-8B2F-144FD1178982Q24816819-F9084035-AEA0-4AA3-9096-180C92BE0643Q26744834-FE9626E5-EBB8-4D6A-9865-36397B76B7E9Q26766681-1CAEFD39-3B82-4232-88CC-584D0FE2788AQ26771732-4FA506BF-A5A3-4B6C-B001-ED4127976ECEQ26774381-99217367-6891-4801-A3F0-C00AF4B857FEQ26827066-1A2EE096-EB34-42F5-8C0E-F73AAB849E1DQ26830682-C78819DB-F8CB-46AB-B03D-03E18D930355Q26995918-7D378B62-005B-4F3F-9A73-B8224025292CQ27004724-275C9D0F-8ED6-45D8-9AA8-B606CAF580F6Q27010785-44AD61D9-C609-4299-AE7E-A5D6900773DAQ27022467-1895920C-F2BC-46F0-80DA-7E2990897BC8Q27315907-57FFBA54-0655-4D24-91B7-320C85785FF6Q28080551-C3F324F9-91DF-46A5-B64C-0A9BD6838C4CQ28395248-C21A2C46-BADF-4947-B736-3EBA4ABE2A68Q28397425-9919CBB7-AB9E-4933-9A42-7B59000D0DECQ28484823-04900CB7-267E-4633-ABC6-98671B4BCBD3Q28485267-75B5C6F1-880E-4998-8C4C-5EAAA4A4A5BCQ28487451-E76FA5F0-432A-4FE4-8692-886AB7E39F76Q28546877-02EB39EE-9428-4F3F-86E8-922E3044406FQ30152727-64B2615F-52E4-46A5-9024-A9784EB169F2Q30152889-4BBD4F03-00AF-4470-A40C-1296B5E65E4FQ30155110-2B03E032-4ABF-453B-8C97-68F5AFCED00EQ30157432-8E2AD37F-CD4B-40E3-9D43-EBD0B8339AA6Q30157440-75CFC523-ECC2-4237-849E-AF57F1EF8CF2Q30405705-BD18C680-100B-4C8C-B69B-63B7393AAA1AQ30416896-22FF9C86-7E1F-4BCA-994E-6922FA521E51Q30419488-CE6D8B26-4F19-4E50-9C12-C93DCDAA7DFCQ30434734-C65D5022-BEAD-4A8A-8C10-9961384AE04EQ30437131-EDF0749E-BCD9-4955-981E-876B367C9675Q30438164-DA1F4ED2-1FA1-4113-A54F-5FB25AAB0165Q30481429-3740ABF1-102E-4EC5-B787-219756BFDFF3Q30488090-66E8F287-B078-40C8-A227-B15208E7B025
P2860
Permeabilization of lipid bilayers is a common conformation-dependent activity of soluble amyloid oligomers in protein misfolding diseases.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Permeabilization of lipid bila ...... n protein misfolding diseases.
@en
Permeabilization of lipid bila ...... n protein misfolding diseases.
@nl
type
label
Permeabilization of lipid bila ...... n protein misfolding diseases.
@en
Permeabilization of lipid bila ...... n protein misfolding diseases.
@nl
prefLabel
Permeabilization of lipid bila ...... n protein misfolding diseases.
@en
Permeabilization of lipid bila ...... n protein misfolding diseases.
@nl
P2093
P356
P1476
Permeabilization of lipid bila ...... n protein misfolding diseases.
@en
P2093
Brian Edmonds
Charles G Glabe
James E Hall
Rakez Kayed
Saskia C Milton
Theresa M McIntire
Yuri Sokolov
P304
46363-46366
P356
10.1074/JBC.C400260200
P407
P577
2004-09-21T00:00:00Z